- Home
- HOOD vs TAK Comparison
HOOD vs TAK Comparison
Compare HOOD & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOOD | TAK |
|---|---|---|
| Founded | 2013 | 1781 |
| Country | United States | Japan |
| Employees | N/A | 47455 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.3B | 56.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOOD | TAK |
|---|---|---|
| Price | $67.54 | $18.20 |
| Analyst Decision | Buy | |
| Analyst Count | 23 | 0 |
| Target Price | ★ $109.09 | N/A |
| AVG Volume (30 Days) | ★ 21.3M | 2.8M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | ★ 31.41 | N/A |
| EPS | ★ 2.05 | N/A |
| Revenue | ★ $4,473,000,000.00 | N/A |
| Revenue This Year | $24.73 | $0.38 |
| Revenue Next Year | $18.30 | $1.02 |
| P/E Ratio | ★ $34.02 | $41.25 |
| Revenue Growth | ★ 51.58 | N/A |
| 52 Week Low | $33.60 | $12.99 |
| 52 Week High | $153.83 | $18.90 |
Technical Indicators
Market Signals| Indicator | HOOD | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 51.38 |
| Support Level | $63.52 | $17.65 |
| Resistance Level | $84.75 | $18.67 |
| Average True Range (ATR) | 3.19 | 0.27 |
| MACD | 0.32 | 0.01 |
| Stochastic Oscillator | 37.24 | 40.36 |
Price Performance
Historical ComparisonAbout HOOD Robinhood Markets Inc.
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.